Moberg Pharma: All eyes on the European study

Research Note

2020-02-11

17:03

Today's Q4 2020 earnings report was without any major surprises as it should. Moberg confirms the topline results of the EU trial are to be released by the end of Q2. Current cash, we believe, supports operating activities into the fourth quarter this year.

KP

Klas Palin

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.